Mark Cuban's push to place drug manufacturing facilities directly adjacent to hospitals represents the most significant threat to traditional pharmaceutical marketing relationships since the 340B pricing debate erupted. When the intermediary between manufacturer and patient collapses to zero distanc

The FDA has requested additional safety data from Eli Lilly for its oral GLP-1 medication, extending the approval timeline for what would be the first pill form of the blockbuster diabetes and weight loss drug class. For healthcare marketers who have spent 18 months watching GLP-1 demand outstrip su

The three largest for-profit hospital systems in America—HCA Healthcare, Tenet Healthcare, and Community Health Systems—redrew the competitive map in 2025 through a wave of acquisitions and divestitures that fundamentally altered patient access corridors across dozens of markets. For healthcare mark

Medicare's proposed 2.4% payment increase for inpatient hospitals in 2027—paired with a potential mandatory payment model—arrives as hospitals face their most challenging patient acquisition environment in a decade [1]. The reimbursement bump, while modest, masks a deeper strategic shift: CMS is mov

The digital health market entered 2026 with a sobering reality: venture capital flows to fewer companies, and the implications reach far beyond startups scrambling for Series B rounds. For healthcare marketing leaders, this consolidation signals a fundamental shift in vendor stability, partnership r

The White House proposal for a 12% reduction to the Department of Health and Human Services budget in fiscal year 2027 arrives at a moment when the same administration has accelerated drug approvals to historic speeds [1][2]. Healthcare marketing executives face a paradox: faster paths to market pai

AI-powered clinical documentation tools now reduce time spent in electronic health records, according to a 2026 study published in JAMA, but the gains are modest—and healthcare marketers need to understand what that means for patient experience, physician engagement, and competitive positioning [1].

Bipartisan lawmakers are pushing the Centers for Medicare and Medicaid Services to intensify enforcement against Medicare Advantage overpayments in 2026, targeting billing practices that have inflated federal spending on the program for years [1]. The timing matters: as regulatory scrutiny tightens

The nation's 17,000 federally funded community health centers — treating 1 in 7 Americans — are projecting $32 billion in collective losses over five years as Trump's One Big Beautiful Bill Act triggers the largest retrenchment in government-backed healthcare access in decades [1]. Nebraska launched

State governments are writing multimillion-dollar checks to Deloitte, Accenture, and Optum to build the administrative infrastructure that will remove millions of Americans from Medicaid. Wisconsin alone will pay nearly $10.2 million for system changes, Iowa at least $20 million, and Illinois $12 mi